PIQUR Therapeutics AG was founded in 2011 as a spin-off of the University of Basel with a focus on the development of novel drugs based on the inhibition of the PI3K/mTOR pathway, which is deregulated in many cancers and several other diseases.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business